Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Feb 9, 2018 · 10-Q · 40 days after period end · 0001493152-18-001696
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$2.20M | -$3.76M | -$3.56M | -$345.48K |
| EPS Diluted | -$0.20 | -$1.13 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Feb 9, 2018 · 40 d after period end
